key: cord-1020134-zypx2fu9
authors: Khan, M. Imran; Hasan, Kazi Nadim; Sufian, Abu; Hosen, M. Bayejid; Polol, Mohammed Nafiz Imtiaz; Khaleque, M. Abdul; Rahman, M. Mizanur; Chowdhury, M. S. M.; Haider, Hasan Ul; Razu, Mamudul Hasan; Khan, Mala; Rabbi, Mohammad Fazle
title: Reports of Coding-Complete Genome Sequences of Five 2019 Novel Coronavirus (SARS-CoV-2) Strains Isolated in Bangladesh
date: 2020-07-30
journal: Microbiol Resour Announc
DOI: 10.1128/mra.00692-20
sha: 4f58e879d9a7b5eb859057bbbd619a5f3847b5be
doc_id: 1020134
cord_uid: zypx2fu9

This study determined five coding-complete genome sequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strains isolated from oropharyngeal swab specimens of Bangladeshi patients who were diagnosed with coronavirus disease 2019 (COVID-19) and had no travel history.

T he recent emergence of severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, family Coronaviridae, genus Betacoronavirus, first occurred in Wuhan, Hubei Province, China, in December 2019 (1) . Since then, the virus has spread globally, and the World Health Organization (WHO) declared the disease COVID-19 a pandemic on 31 January 2020 (2) . Here, we report the coding-complete genomic sequences of five SARS-CoV-2 strains isolated from Bangladeshi patients with no travel history.

The oropharyngeal swab specimens were collected from Central Police Hospital in Bangladesh for three males and two females within the age range of 18 to 46 years. The same specimens were found to be positive when tested for SARS-CoV-2 using a real-time reverse transcriptase PCR (RT-PCR) kit from Sansure Biotech, Inc. (Changsha, China) and were further sequenced. Viral RNA was extracted using a QIAamp DSP virus spin kit (Qiagen, Hilden, Germany). cDNA was prepared on the same day using a QuantiTect reverse transcription kit (Qiagen, Hilden, Germany) and used as a template for generating amplicons across the SARS-CoV-2 genome using the Ion AmpliSeq SARS-CoV-2 research panel (Thermo Fisher Scientific, Massachusetts, USA), which contains 237 pairs of unique primers in two pools specific for SARS-CoV-2. High-throughput sequence libraries were prepared using the Ion AmpliSeq library kit plus (Thermo Fisher Scientific) per the manufacturer's protocol. The prepared libraries were quantified in a Qubit 4 fluorometer using a Qubit double-stranded DNA (dsDNA) high-sensitivity (HS) assay kit. The individual libraries were then diluted to 100 pM, pooled, and prepared for clonal amplification on the Ion OneTouch 2 instrument using the Ion 520 and 530 OT2 kits. The clonally amplified libraries were then enriched in an Ion OneTouch ES system and loaded onto an Ion 520 chip for the sequencing run. The sequencing was performed on an Ion GeneStudio S5 instrument (Thermo Fisher Scientific).

Around 7.7 million reads were generated for 5 samples. The data generated were mapped to the Wuhan virus reference sequence (GenBank accession number NC_045512) and were assembled into a consensus sequence using the built-in IRMA plugin v1.2.1.0 (3) on the Ion Reporter v5.10.0 system with default parameters. The consensus sequences were annotated using the SnpEff annotation tool v1.2.1.0 COVID-19 plugin. The assembled consensus genomic sequences were then submitted to the GenBank database. More than 98% of all the reads generated from the sequencing run were successfully mapped to the Wuhan reference genome (Table 1) .

Five SARS-CoV-2 sequences from the study were compared to existing genomes using online NCBI BLAST (https://blast.ncbi.nlm.nih.gov/Blast.cgi). Comparison of our five isolate genomes (GenBank accession numbers MT566434, MT566435, MT566436, MT566437, and MT566438) revealed 99.97%, 99.96%, 99.96%, 99.98%, and 99.97% nucleotide identities, respectively, with the Wuhan virus reference sequence (NC_045512). 

SARS-CoV-2: an emerging coronavirus that causes a global threat

WHO. 2020. Coronavirus disease (COVID-2019) situation reports: situation reports March 2020 -situation report 54

Viral deep sequencing needs an adaptive approach: IRMA, the iterative refinement meta-assembler

We gratefully acknowledge the assistance and support from the physician and laboratory staffs of DNA Solution Ltd., the Central Police Hospital, and the Designated Reference Institute for Chemical Measurements during the collection of samples from participants. We are grateful to all of the patients who gave consent to participate in this study.